Introduction the adipose tissue comprises one of the largest organs in the body. even lean adult men and women have at least 3.0-4.5 kg of adipose tissue, and in individuals with severe obesity, adipose tissue can constitute 45 kg or more of body weight. the adipose organ is complex, with multiple depots of white adipose tissue involved in energy storage, hormone (adipokine) production and local tissue architecture, as well as small depots of brown adipose tissue, required for energy expenditure to create heat (nonshivering thermogenesis).
excessive accumulation of white adipose tissue in individuals with obesity causes insulin resistance and increases the risk of many metabolic disorders. the realization that brown adipose tissue and adipokines produced by white adipose tissue have beneficial effects on metabolism has, however, raised the possibility that transplantation of adipose tissue might have therapeutic benefits. adipose tissue is also a major source of adultderived multipotent stem cells. this review summarizes our current knowledge about the biology of these adipose tissue depots and how transplantation of adipose tissue or adipose-derived stem cells could provide new insights into the physio logical roles of adipose tissue and the benefi cial effects for the management of metabolic disease.
Properties of adipose tissue depots
Subcutaneous and visceral white adipose tissue white adipose tissue is distributed throughout the body in the form of two major divisions or types: subcutaneous adipose tissue and the intra-abdominal visceral adipose tissue. these two major adipose tissue depots have differen tial metabolic effects. epidemiological studies have found that increased visceral adipose tissue, that is, central obesity (determined by large waist circumference or high waist-hip ratio), is associated with adverse health risks, such as insulin resistance, type 2 diabetes mel litus, dyslipidemia, hypertension, atherosclerosis, hepatic steatosis, cholesterol gallstones and overall mortality ( Figure 1 ). [1] [2] [3] [4] [5] Consistent with this notion, the removal of visceral adipose tissue (omentectomy) decreases insulin and glucose levels in humans. 6 in animal models, this procedure reduces serum cholesterol and triglyceride levels, improves hepatic and peripheral insulin sensitivity and increases life span. [7] [8] [9] [10] By contrast, peripheral obesityincreased subcutaneous adipose tissue mass mainly in the region of the buttocks and thighs-seems to be associated with improved insulin sensitivity and a lower risk of develop ing type 2 diabetes mellitus than is reported in indivi duals with central obesity (Figure 1) . 11, 12 indeed, although not often noted, individuals with combined peripheral and central obesity have lower levels of plasma glucose, insulin and triglycerides, increased glucose uptake into tissues and lower aortic atherosclerosis scores than individuals with visceral obesity alone. 13, 14 not surprisingly, therefore, removal of subcutaneous adipose tissue by liposuction without changes in lifestyle factors does not improve any aspect of the metabolic syndrome 15, 16 and can even lead to increased intra-abdominal adipose tissue accumulation (r. H. eckel, personal communication).
the protective effects of subcutaneous adipose tissue and detrimental effects of visceral adipose tissue have
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RevIewS been ascribed to a number of mechanisms. Firstly, subcutaneous and visceral adipocytes have cell-autonomous properties owing to inherently different progenitor cells that reside in each adipose tissue depot. these cellautonomous characteristics were demonstrated in vitro by the depot-specific rates of replication, apoptosis, lipid accumulation and gene expression profiles that persisted for 40 population doublings in preadipocyte strains derived from single subcutaneous or visceral human preadipocytes with stable expression of the telomerase gene, which maintains the integrity of chromosome ends and thereby genome stability. 17, 18 secondly, the antilipolytic effect of insulin to promote adipose tissue storage is greater in subcutaneous adipose tissue than in visceral adipose tissue, as shown using a palmitate tracer during hyperinsulinemic-euglycemic clamp studies. 19 the differential effects of insulin in each adipose tissue depot are mediated, in part, by increased insulin receptor autophosphorylation, as well as increased signal transduction through the insulin-receptor substrate (irs) 1-associated phosphatidylinositol 3-kinase (Pi3K) pathway in subcutaneous adipose tissue. 20 Human sub cutaneous adipocytes are also less responsive to the lipolytic action of catecholamines (epi nephrine and norepinephrine). these cells express high levels of α 2 -adrenergic receptors, which inhibit the activation of adenylate cyclase and lipolysis, and low levels of β 1 -adrenergic and β 2 -adrenergic receptors, which stimulate the activation of adenylate cyclase and lipo lysis. 21 Parenthetically, the role of β 3 -adrenergic receptors in mediating lipolysis under physiological conditions in humans does not seem to be as great as their role in rodents. as a result of increased lipolysis, individuals with central obesity have increased postprandial release of nonesterified fatty acids from visceral adipose tissue into the hepatic portal vein, which contribute to hepatic insulin resistance. 22, 23 Gonadal steroids have also been shown to affect the metabolism of adipose tissue. low serum testosterone levels, for example, in individuals with hypogonadism or central obesity, are associated with insulin resistance in humans, whereas castration of male mice results in increased glucose uptake into adipose tissue. [24] [25] [26] By
Key points
Mammals have three main metabolically active adipose tissue depots: white ■ subcutaneous adipose tissue, white visceral adipose tissue and brown adipose tissue, located primarily in the neck, mediastinum and interscapular areas visceral white adipose tissue is associated with insulin resistance and diabetes ■ mellitus, whereas subcutaneous white and brown adipose tissue have intrinsic beneficial metabolic properties
The goal of adipose tissue transplantation has evolved from the early uses for ■ reconstructive surgery to the study of adipocyte biology, and now, as a potential tool to improve metabolism Adipose-derived stem cells can give rise to several cell lineages and could be of ■ value for the repair or regeneration of various cell types and for the treatment of diseases Current research is investigating various approaches of adipose tissue ■ transplantation, including new sources of adipocyte progenitors, novel approaches to ex vivo engineering and manipulations to achieve a desired cell type contrast, administration of testosterone in men can favorably decrease visceral adipose tissue mass and increase both subcutaneous adipose tissue mass and insulin sensitivity. 25 Premenopausal women often have increased amounts of subcutaneous and total adipose tissue compared with men, 27, 28 whereas postmenopausal women are prone to an increase in visceral adipose tissue mass. 29 Hormone replacement therapy after menopause attenuates central obesity, but increases the risk of coronary vascular disease and breast cancer. 25 in female mice, adipose tissue mass and adipocyte size increase after ovariec tomy, concomitant with a decline in insulin sensi tivity and glucose uptake. 26 sexual dimorphic effects on adipose tissue metabolism can also involve other factors such as leptin and other interactions in the brain. 25 the adipokine adiponectin is present in serum in the form of trimers, hexamers and high-molecular-weight multimers; the high-molecular-weight form of adiponectin has insulin-sensitizing, 30 ,31 antiatherosclerotic 32 and anti-inflammatory properties, and is secreted more abundantly from subcutaneous adipose tissue than visceral adipose tissue. [33] [34] [35] when obese ob/ob mice, which carry a mutation in the leptin gene, are engineered to overexpress adiponectin in adipose tissue, insulin sensitivity, diacylglycerol levels and β-cell function improve, lipid clearance increases and hepatic steatosis is reduced, despite a massive further increase in subcutaneous adipose tissue mass. 36 By contrast, resistin and retinol-binding protein (rBP) 4 are adipokines associated with insulin resistance and type 2 diabetes mellitus, which are more abundantly secreted from visceral than subcutaneo us adipose tissue. [37] [38] [39] [40] Previous studies suggest that the properties of adipocytes in different adipose tissue depots could represent an intrinsic heterogeneity of adipocytes and that these properties and the distribution of adipose tissue in dif ferent depots might be regulated by fundamental develop mental genes. 41, 42 For example, the expression of t-box transcription factor tBX15, a mesodermal develop mental gene, is higher in visceral than sub cutaneous adipocytes of lean individuals. in patients with obesity, expression of tBX15 is less abundant in visceral than subcutaneous adipose tissue. the glycoinositol phosphate-linked membrane protein glypican-4 shows the opposite expression profile. 41 these expression patterns are also observed in pre adipocytes from the same adipose tissue depot (Figure 1) . adipose function and distribution might also be affected by molecules involved in signal transduction. For example, the BDnF, nt-3 growth factors receptor (also known as neurotrophic tyrosine kinase receptor type 2 [ntrK2]) is expressed at higher levels in sub cutaneous adipose tissue than in visceral adipose tissue, 43 and mutations of NTRK2 have been found in children with severe obesity. 44 micrornas (mirnas)-small non-coding rnas that can regulate biological processes-can also have a depotspecific expression. Human sub cutaneous adipose tissue expresses the mirnas mir-92, mir-95, mir-181a and mir-311, which are all negatively correlated with adipocyte volume, whereas mir-145 is highly expressed in visceral adipose tissue in patients with type 2 diabetes mellitus ( Figure 1 ). 45 reviewS adipose tissue is also a major site of inflammation, which might link obesity to insulin resistance. the visceral adipose tissue depot contains higher levels of macrophages, t cells, and natural killer cells [46] [47] [48] ) than does subcutaneous adipose tissue. thus, increased inflammation produced by excess visceral adipose tissue increases the risk of obesity-related diseases and mortality.
Finally, subcutaneous and visceral adipose tissue depots have intrinsically different responsiveness to drugs, such as the insulin-sensitizing thiazolidinediones. thiazolidinediones bind to the transcription factor peroxisome proliferator-activated receptor γ (PParγ), a nuclear receptor involved in adipocyte differen tiation. subcutaneous adipose tissue contains higher basal levels of PParγ1 and PParγ2 and is more responsive to thiazolidine diones than visceral adipose tissue. 54 thus, treatment with thiazolidinediones leads to an increase in subcutaneous adipose tissue mass [55] [56] [57] and an associated improvement in insulin sensitivity. treatment with thiazolidine diones also increases adiponectin content and secretion from subcutaneous adipocytes, but not from visceral adipocytes. 58, 59 these mechanisms account for at least part of the differen tial metabolic properties between sub cutaneous and visceral adipose tissue and suggest that trans plantation of subcutaneous adipose tissue mass could help to promote the beneficial metabolic effects mediated by this depot.
Brown adipose tissue
Brown adipose tissue differs from white adipose tissue by its large number of mitochondria, multilocular (rather than unilocular) lipid droplets, a high degree of vasculariza tion and sympathetic innervation and, most importantly, expression of uncoupling protein (uCP) 1. uCP1 is a mitochondrial protein that uncouples oxidative phosphorylation, which results in inefficient production of atP and release of energy in the form of heat as part of the process of nonshivering thermogenesis. transgenic overexpression of uCP1 in the white adipose tissue of mice prevents obesity, 60 whereas genetic ablation of uCP1 in mice maintained at thermoneutral temperature results in increased energy storage from food intake with subsequent development of obesity. 61, 62 a similar effect can be seen with the genetic ablation of brown adipose tissue, which decreases thermogenesis and induces obesity in mice. 63 thus, the primary metabolic function of brown adipose tissue is to increase energy expenditure and heat production ( Figure 1) . the brown adipose tissue depot in rodents and newborn humans is mainly localized to the inter scapular and paraspinal areas. in adult humans, uCP1-positive brown adipose tissue could also be identified in these areas at autopsy, but this brown adipose tissue was thought to be nonfunctional. 64 [67] [68] [69] [70] [71] [72] Biopsy of adipose tissue in these areas shows a hetero geneous morphology with a mixture of brown and white adipose tissue cells. [73] [74] [75] in rodents, and potentially in humans, brown adipocytes can be induced to differentiate upon exposure to cold or β-adrenergic receptor agonists. [75] [76] [77] evidence of brown adipose progenitor cells in white adipose tissue of mice has been demonstrated by the forced expression or treatment with critical transcriptional regulators of brown adipogenesis that induces the differentiation of cells from the stromal vascular fraction (svF) of white adipose tissue into brown adipocytes, in vitro. 78, 79 in addition, small amounts of brown adipose tissue can be found interspersed between skeletal muscle bundles in mice and humans. 80, 81 these intermuscular depots of diffuse brown adipocytes have been suggested to help protect some strains of mice from obesity. 80 to date, two types of progenitors of brown adipocytes have been determined. the first type of pro genitor cell is present in interscapular brown adipose tissue, expresses myogenic factor 5 (myf5), a regulatory factor expressed in muscle-cell precursors, 82 and displays a myogenic transcriptional signature. 83 these results suggest that progenitors of interscapular brown adipocytes are common precursors to those of myoblasts. the second type of progenitor cell for brown adipocytes is present in white adipose tissue and skeletal muscle, is myf5-negative in both tissue types, 81, 82 is more sensitive to β-adrenergic receptor agonists, 80, 82 and displays different onset of uCP1 expression during developmental growth 84 compared with progenitors in the interscapular brown adipose tissue. additional studies are needed to further characterize the progenitors of brown adipocytes in humans.
in individuals studied under ambient conditions (~22 °C), active brown adipose tissue, determined by high uptake of 18 F-FDG in Pet-Ct scans, is detectable in only about 3% of men and 7% of women. 69 in indivi duals subjected to a 2-h cold exposure, the prevalence of detectable active brown adipose tissue in lean indivi duals increases up to 96%. 67, 72 Brown adipose tissue in lean individuals is more easily detected and more active than in those with overweight or obesity. 67 indeed, acti vity of brown adipose tissue is inversely related to the percentage of total body fat mass 67, 72 and Bmi 67, 69, 72 in most, but not all, studies. 85 Furthermore, glucose tolerance in individuals with obesity and high levels of uCP1 is better than that in individuals with obesity and low levels of uCP1, suggesting a beneficial metabolic effect of active brown adipose tissue. 86 increased glucose uptake into brown adipose tissue is inversely correlated with fasting levels of glucose. 69, [87] [88] [89] insulin levels are also weakly, but significantly, inversely associated with the activity of brown adipose tissue in lean individuals. 72 overall, these data suggest that upregulation of brown adipose tissue activity can contribute to a lean and metabolically healthy phenotype in humans. these findings also suggest that transplantation or stimulation of brown adipose tissue might be used as a therapeutic approach to increase energy expenditure, lower white adipose tissue mass and improve overall metabolism.
Transplantation of adipose tissue
adipose tissue transplantation has been the subject of experimentation for over 100 years. the goal of adipose tissue transplantation has evolved substantially over the years, from the improvement of appearance in reconstructive surgery, to the study of the biology of adipose tissue, to the potential induction of beneficial metabolic effects and treatment of diseases, such as obesity, lipo dystrophy or cardiovascular disease.
reconstructive surgery as early as 1893, neuber reported transplantation of adipose tissue from the arm to fill depressions in the face caused by tuberculosis. 90 the main technical problem of using adipose tissue for reconstructive surgery has been the maintenance of graft volume and viability while minimizing the inflammatory response. 91 adipose tissue is currently used in reconstructive and other surgeries for esthetics and to provide structural support. unfortunately, there has been no thorough charac terization of individuals who undergo adipose tissue transplantation, so the metabolic effects of this procedure are unknown.
Understanding the biology of adipose tissue experimental adipose tissue transplantation in rodents has involved both subcutaneous and visceral white adipose tissue, as well as brown adipose tissue (Figure 2a ). the studies have examined the survival, vascularization and innervation of the adipose tissue grafts, the metabolic effects of adipose tissue transplantation and the effects of adipose tissue grafts on endogenous adipose tissue growth.
Transplantation of white adipose tissue some of the earliest studies to examine the development of adipose tissue in rodents (table 1) were performed by Hausberger, who transplanted immature, peri gonadal adipose tissue cells that were devoid of lipid and morphologically indistinguishable from fibroblasts from 5-day old rats into either a subcutaneous or visceral site of recipient rats. 92, 93 Hausberger demonstrated that these immature adipose tissue cells could become whole adipose tissue pads that shrank or grew upon starvation or over feeding, respectively, whereas transplanted connective tissue cells from the fascia did not develop into adipose tissue pads. iyama and colleagues 94 showed that after adipose tissue cells were transplanted sub cutaneously, more cells underwent differentiation when in proximity to capillaries, suggesting that vascularization of adipose tissue grafts is essential for the growth of adipose tissue pads. when adipose tissue is transplanted between lean and obese mice, the adipose tissue cells in the grafts grow or shrink to those of the host in size and fatty acid composition. thus, the transplants seem to respond similarly to normal adipose tissue pads, and the host environment is important in determining some aspects of adipose tissue cell fate.
95-97 the adipose tissue grafts used in these studies, however, were reviewS generally small (5-10 mg), and the effects on whole-body metabolism were not examined.
other studies of whole-adipose tissue transplantation examined the regulation of total adipose tissue mass. transplantation of perigonadal adipose tissue to a subcutaneous site in the recipient mouse initially resulted in a decrease in total adipose tissue mass after 2 weeks, but this difference was no longer statistically significant 5 weeks after transplantation as the adipose tissue grew. 98 Generally, it was perceived that removal and/or trans plantation of subcutaneous adipose tissue to subcutaneous sites induced less growth of total adipose tissue mass than did removal and/or transplantation of visceral adipose tissue.
99,100
Transplantation of preadipocytes and SVF In vivo models of adipocyte development in rodents have been generated with the use of preadipocyte cell lines, such as 3t3-F422a, [101] [102] [103] [104] [105] [106] [107] and cells from the svF of adipose tissue from rodents (table 2) . [108] [109] [110] [111] [112] [113] [114] Preadipocytes are mesen chymal cells that are committed to develop along the adipocyte lineage in response to appropriate developmental cues. the svF, obtained by collagenase digestion of adipose tissue and centrifugation to remove the mature adipo cytes, is a mixture of cells including preadipocytes, fibroblasts, vascular cells, blood cells and macrophages. at present, preadipocytes cannot be morphologically distinguished from fibroblasts and a population of mesenchymal stem cells, which also reside in the svF. these mesenchymal stem cells are multipotent cells that can give rise to several cell lineages such as adipocytes, osteoblasts and chondrocytes.
although cell culture studies provide good models of differentiation in vitro, adipose tissue pad development in vivo, after transplantation (table 2), requires cell lines with a very high potential for proliferation and differentiation (for example, 3t3-F442a are more suitable than the 3t3-l1, 3t3-C2 and ob17 cell lines [101] [102] [103] ). transplantation of svF from flank, epididymal, omental and perirenal adipose tissue formed adipose tissue pads in rodents, [108] [109] [110] [111] [112] whereas bone marrow-derived fibroblasts 108 and skin fibroblasts 109 did not form adipose tissue pads. in addition, confluent preadipocytes, 102 dedifferentiated primary mature adipocytes 113 and svF 110 engraft more efficiently than fully differentiated cells 102 or mature adipocytes. 114 successful trans plantation requires a high degree of vascularization as shown by the localization of adipose tissue grafts near large blood vessels, as well as the absence of adipose tissue grafts upon administration of intra peritoneal injections of an antibody against vascular endothelial growth factor (veGF). 102, 104, 109 when pre adipocyte cell lines are seeded into a matrix, such as matrigel® (Becton Dickinson and Company, Franklin lakes, nJ, usa), 105 polyglycolic acid scaffold 106 or collagen, 109 they show slower rates of maturation, but increased content of Dna and triglycerides, high vasculariza tion and less necrosis than cells without scaffolds. in some of these experiments which use scaffolds, tracking the development of the transplanted preadipocytes has been facilitated by stable transfection with a β-galactosidase transgene, 102 incubation with the dye PKH26 110 or expression of green fluorescent protein. 104 in an interesting experiment investigating the role of the transplantation site on adipose tissue cell function and metabolism, shibasaki et al. 107 demonstrated that implantation of 3t3-l1 preadipocyte cells into a subcutaneous site in mice improved metabolism, indicated by decreased glucose and insulin levels during a glucose tolerance test, whereas implantation of 3t3-l1 cells into a visceral mesen teric site worsened metabolism, as shown by increased levels of serum insulin, triglycerides and tumor necrosis factor (tnF).
Transplantation of brown adipocytes successful transplantation of brown adipose tissue has been achieved in rodents using small clusters of brown adipose tissue, 115 whereas very small grafts (1-3 mg), 116 isolated preadipocytes or mature brown adipocytes 115 tend to undergo necrosis when transplanted (table 3) . the development of immature brown adipose tissue transplanted into the eye of adult hamsters has been characterized and a sequence of events which begins with the vascularization and proliferation of the unilocular brown b | Transplantation of subcutaneous flank adipose tissue into the visceral cavity of mice induces beneficial metabolic effects, such as decreased body weight, decreased adipose tissue mass and improved insulin sensitivity. 134 These effects are not mediated by inflammation, adiponectin or leptin, but might be mediated by decreased levels of resistin. Abbreviations: HMw, high molecular weight; IL-6, interleukin 6; NS, no significant change in; TNF, tumor necrosis factor. reviewS adipose tissue graft, followed by innervation at day 10 and subsequent proliferation of brown adipocyte precursors near capillaries, increased mitochondrial ultrastructure and development of multilocular lipid droplets has been described. 117 when intraocular transplantation was performed after sympathetic denervation, differentiation of brown adipocytes still occurred, but was slower and less robust than without previous sympathetic denervation. 117 Brown adipose tissue has also been transplanted under the kidney capsule, 118 but no innervation was observed in this location, even after 2 weeks. the morphological characteristics of brown adipose tissue are different between lean and obese mice. in lean mice, brown adipocytes are small, have multilocular lipid droplets, dense mitochondrial structure and both the adipo cyte and nearby capillaries are innervated. 119 By contrast, brown adipocytes of obese ob/ob mice are larger, have unilocular lipid droplets, sparse mito chondria and innervation leads primarily to the capillaries and only a few to the brown adipocytes themselves. transplantation of brown adipose tissue between obese and lean mice showed that morphological transformation of brown adipose tissue to that of lean mice could be induced by extreme cold exposure (4 °C for 5 weeks), but not with normal or warm temperature exposure (23 °C or 33 °C). 119 moreover, after 5 weeks of cold exposure, the brown adipose tissue graft still maintained a morphological appearance similar to that found in lean mice after being returned to 23 °C for another 3 weeks. transplantation of brown adipose tissue between obese or lean mice also indicated that the host environment of the adipose tissue graft, rather than the donor of the adipose tissue, played a major part in de termining the fatty acid composition of the graft. 120 
Metabolic effects of transplantation
White adipose tissue lipodystrophies are genetic or acquired syndromes caused in part by the inability to form lipid droplets in adipocytes. at a clinical level, lipodystrophies are characterized by a substantial loss of whole body adipose tissue (either complete or partial), insulin resistance, dyslipidemia, hepatic steatosis, hypertension and/or diabetes mellitus. 121 the transgenic a-ZiP/F-1 mouse, which carries a dominant-negative transcription factor that inhibits adipose differen tiation, has virtually no adipose tissue and a phenotype which resembles that of humans with severe lipodystrophy. transplantation of perigonad al or subcutaneous adipose tissue from a wild type mouse reviewS to the subcutaneous region of the lipodystrophic a-ZiP/F-1 mouse greatly improves its metabolism with decreased food intake, reduced glucose and insulin levels, decreased hepatic steatosis, as well as increased insulin sensitivity and glucose uptake into muscle (table 4) . 122, 123 transplantation of adipose tissue also improves histo logy of β cells and increases insulin positivity on immunostaining. thus, the researchers postulate that the primary cause of the metabolic profile of lipoatrophic diabetes mellitus is the lack of adipose tissue, which results in a lack of leptin secretion, adipose uptake of glucose, triglyceride and/or free fatty acids and increased synthesis of tri glycerides by the liver. subsequent storage of triglycerides in the liver and muscle can then adversely affect glucose metabolism. when adipose tissue grafts obtained from leptin-deficient ob/ob mice were transplant ed into lipo dystrophic a-ZiP/F-1 mice, no reversal of metabolic abnormalities was observed. 124 thus, the mechanism by which the transplantation of adipose tissue improved metabolism required leptin secretion and could be reproduced by leptin administration. 124 subsequently, other studies have shown that administration of leptin to humans with lipoatrophic diabetes mellitus can also dramatically reverse insulin resistance, hepatic steato sis and serum triglyceride levels. 125 this treatment, however, is not without adverse effects, because leptin administration also stimulates the immune system. 126, 127 Clearly, if transplantation of adipose tissue could be performed successfully in lipodystrophic patients, then daily leptin injections would no longer be needed. 
reviewS
Diacylglycerol o-acyltransferase (DGat) 1 is a key enzyme in the synthesis of triglycerides in mammals. adipose tissue isolated from mice that lack DGat1 consist of small adipocytes. transplantation of peri gonadal adipose tissue from mice that lack DGat1 into a subcutaneous site of ob/ob mice or agouti yellow mice (strains that are obese despite normal leptin-receptor function) improved metabolism, as demonstrated by decreased body weight and adipose tissue pads, tri glycerides in muscles and serum tnF, as well as increased adipo nectin mrna in the adipose tissue graft, whole-body insulin sensitivity and energy expenditure. 128 adipose tissue grafts that lack DGat1 also enhanced glucose tolerance in normal wild type mice and agouti yellow mice, but not in ob/ob mice, possibly because the degree of obesity in ob/ob mice is too severe. the in vestigators postulate that increased adiponectin production and activity (owing in part to less inhibitory effects of tnF on adiponectin's expression), as well as increased expression of uCP1, might account for the improved metabolic profile and increased energy expenditure. 128 transplantation of perigonadal adipose tissue from wild type mice into a subcutaneous site of ob/ob mice restored metabolism with normalization of plasma levels of leptin, insulin, glucose and corticosterone, improved the results of glucose and insulin tolerance tests and decreased food intake and body weight (table 4) . 129 in addition, because of leptin's role in immune function, this transplantation restored immune function by a reduction in the amount of apoptosis of immature thymo cytes to normal levels, an increase of thymus and spleen cell number to normal values and normalization of il-6 levels. 130 obese Zucker 132 showed that epididymal adipose tissue sutured to the visceral side of the peritoneum improved glucose tolerance and decreased the levels of glucose and insulin. However, the placement of the epididymal adipose tissue graft potentially did not allow drainage of its circulation directly into the hepatic portal vein, which is characteristic of visceral adipose tissue, and thus might account for the lack of adverse effects on liver metabolism. moreover, the adipocytes in the graft were substantially smaller than those of endogenous epididymal adipose tissue, and small adipose tissue cells are associated with increased insulin sensitivity. 133 Consequently, the intra-abdominal adipose tissue graft in this model seems to have lost its detrimental cell-autonomous properties.
this question was addressed by a four-way study, 134 in which visceral adipose tissue was transplanted into either sub cutaneous or visceral depots, whereas subcutaneous adi pose tissue was transplanted into either sub cutaneous or visceral depots. transplantation of about 1 g of subcutaneous flank adipose tissue into the visceral cavity of wild type C57Bl/6 mice decreased body weight, total adipose tissue mass, plasma insulin and glucose levels, as well as improved glucose tolerance and whole-body insulin sensitivity and increased insulin-mediated suppression of hepatic glucose production (Figure 2b ). 134 as these transplants were allografts, the graft did not seem to cause inflammation and no increase in mrna expression of the macrophage cell surface glycoprotein F4/80 or il-6 or tnF was detected in the engrafted tissue. Plasma levels and mrna expression of adiponectin and leptin in the adipose tissue graft were either unchanged or decreased, which suggests that these adipokines do not mediate the beneficial effects of subcutaneous adipose tissue in this model. expression of the insulin resistance-associated adipo kine resistin 37 did decrease in the graft; however, whether this reduction explains the protective metabolic effect of the transplant remains to be elucidated. transplantation of subcutaneous flank adipose tissue to a sub cutaneous site in the recipient also markedly decreased body weight, adipose tissue mass and plasma glucose, as well as increased glucose uptake into adipose tissue and hepatic insulin sensi tivity, but to a lesser extent than transplantation of subcu taneous adipose tissue into the visceral cavity. the adipocytes of the transplanted subcutaneous adipose tissue graft shrunk notably in size, showed increased glucose uptake during a hyperinsulinemic-euglycemic clamp and had similar gene expression levels of PPARγ and fatty acid synthase compared with that of endo genous sub cutaneous and epididymal adipocytes. thus, the sub cutaneous adipose tissue graft maintained, or even enhanced, its beneficial metabolic profile when transplanted into the visceral area. By contrast, transplantation of epididymal adipose tissue into the visceral cavity or to a subcutaneous site had no beneficial metabolic effects, indicating that the effects of subcutaneous adipose tissue are owing to its cell-autonomous properties. these results suggest a crosstalk between the subcutaneous adipose tissue graft placed in the visceral cavity and the liver of the recipient mouse, where suppression of glucose production by insulin improved. the mechanism for this crosstalk is not known, but could be due to the fact that secreted factors from subcutaneous adipose tissue, when present in sufficient concentration, act on nearby tissues, such as the liver, in the recipient. Hocking et al. 135 showed that trans plantation of subcutaneous adipose tissue to the visceral cavity in mice fed a high-fat diet did not affect body weight, but improved metabolism via a decrease in adipose tissue mass and an improvement of glucose tolerance. thus, transplantation of subcutaneous adipose tissue induces several beneficial metabolic effects in rodents; however, whether these findings can be extrapolated to humans remains to be determined.
Brown adipose tissue the notion of transplanting brown adipose tissue to increase energy expenditure and improve metabolism is an appealing one. as the amount of endogenous brown adipose tissue is very limited, identification and manipula tion of critical regulators of brown adipose tissue differen tiation have been used to engineer brown adipose tissue in order to induce beneficial effects (table 5) . Bone morpho genetic protein (BmP) 7 is a member of the transforming growth factor β (tGF-β) superfamily and can regulate aspects of embryo genesis and organogenesis. 136 C3H10t1/2 multi potent progenitor cells treated with BmP7 and transplanted into nude mice have been shown to develop into an adipose tissue pad that contains uCP1-positive, multilocular brown adipocytes and white unilocular adipocytes. 78 similarly, Pr domain zinc finger protein (PrDm) 16, a protein which forms a transcriptional complex with the active form of CCaat/enhancerbinding protein β (C/eBPβ), has been shown to induce brown adipocyte differentiation in a fibroblast cell line, 79 reviewS primary mouse myoblasts, 82 and human and mouse skin fibroblasts. 137 the resultant brown adipose tissue pad contained uCP1-positive, multilocular and unilocular adipose tissue cells, had high glucose uptake in a Pet scan and increased in vitro respiration. 137 these and other approaches are being explored as potential therapies for the treatment or prevention of obesity.
Adipose-derived stem cells adipose-derived stem cells (asCs) are a population of multipotent cells that can be isolated from adipose tissue by their adherence to plastic. [138] [139] [140] asCs have the ability to undergo self-renewal. upon specific developmental cues, asCs have been shown to differentiate into various cell lineages, including white or brown adipocytes, osteocytes, chondrocytes, neurons, myocytes, leukocytes, endothelial cells, hepatocytes, epithelial cells and pancreatic β cells. Clearly these cells are multipotential, although evidence for the differentiation of asCs into some of these li neages, such as neurons and pancreatic β cells, is not fully established and remains debatable. indeed, asCs that develop further along the adipocyte lineage in response to ap propriate develop mental cues subsequently become committed preadipocytes. the multilineage capacity of asCs offers the potential to repair, maintain or enhance various tissues. 139 141 specific adipocyte progenitors have been isolated from svF of mice using flow cyto metry and the cell surface markers sca-1 + (stem cell antigen, present on preadipocytes), CD34 + , CD45
-and CD31 -. 142-144 these adipocyte progenitors have been shown to form white adipose tissue in mice [142] [143] [144] (table 5) . in one study, a population of asCs retained its multipotent ability to differentiate into bone, cartilage, and muscle in vitro in response to appropriate cues. 143 interestingly, some cells from human skeletal muscle (CD146 -[endothelial cell marker], CD34 + and CD45 -) differen tiate into brown adipo cytes that express uCP1 and have uncoupled respira tion in vitro. 81 asCs have been shown to expand in vitro with similar or Abbreviations: BMP7, bone morphogenetic protein 7; C/eBPβ, CCAAT-enhancer-binding protein β; CIDEA, cell death-inducing DNA fragmentation factor-alpha-like effector A; FACS, fluorescence activated cell sorting; GFP, green fluorescent protein; Linˉ, lineage negative which is CD45 negative (hematopoietic), CD31 negative (endothelial), α7integrin negative (smooth/skeletal muscle); MeFs, mesenschymal embryonic fibroblasts; PDGFRβ, platelet-derived growth factor receptor; PPARγ, peroxisome proliferator-activated receptor gamma; PRDM16, PR domain-containing protein 16; SvF, stromal vascular fraction; UCP1, uncoupling protein 1; wT, wild type.
reviewS greater efficiency of differentiation, 145 degree of angiogenesis 141, 146 and reduction of t-cell activation 147 than the well-characterized bone-marrow-derived mesenchymal stem cells, even though these cells differ at the transcription al and pr oteomic level. 148 liposuction of subcutaneous white adipose tissue is a minimally invasive procedure with low morbidity that allows isolation of asCs and adipocyte progenitors in sufficient quantity for autologous trans plantation. 149 transplantations of asCs obtained from human lipoaspirates have been performed successfully for reconstructive surgery of breast and used to close fistulas associated with Crohn disease (table 6) . 150, 151 transplantation of asCs into hearts for myocardial regeneration after a heart infarct has also been success ful in animal models. 152, 153 these findings have led to ongoing clinical trials that aim to examine the safety and efficacy of transplanted asCs to improve cardiac function in patients with myocardial ischemia or infarction (table 6) . additional clinical trials are assessing the metabolic effects of transplanting asCs in patients with lipodystrophies. in a very specialized study, patients who have overcome childhood leukemia and are at an increased risk of developing obesity owing to treatments such as steroids and cranial radiotherapy are being studied for the possible beneficial effects of asCs transplantation on blood pressure, cholesterol levels, Bmi and incidence of diabetes mellitus. outside the area of metabolism, thousands of autologous transplantations the mechanisms underlying the effects of asCs transplantation might initially involve paracrine actions of factors secreted from the asCs, such as cytokines and growth factors, 155 which can affect immuno modulatory properties [156] [157] [158] and angiogenesis, as well as induce differentiation of the asCs into various lineages. regulation of asCs by mirnas has also been reported. 159 Approaches and limitations of transplantation white adipose tissue as with lipodystrophic mice, transplantation of adipose tissue from wild type mice into ob/ob mice normalizes energy balance and metabolism by increasing plasma leptin levels. 129, 130 the majority of humans with obesity, however, show no deficiency in leptin production, 160 but have developed varying degrees of leptin resistance. thus, administration of recombinant leptin over 6 months to patients with obesity in a placebo-controlled trial did not produce the anticipated dramatic reduction in body weight in the majority of study participants. 161 transplantation of adipose tissue for the sole purpose of raising leptin levels to treat the majority of individuals with obesity is, therefore, not applicable. Certain adipose tissue depots, however, have other properties which may produce be neficial metabol ic effects.
Brown adipose tissue as with any procedure, potential concerns about adipose tissue transplantation as a viable clinical approach remain. supraphysiological levels of brown adipocytes might cause detrimental effects. For example, over expression of uCP1 in mice increased visceral adipose tissue and decreased subcutaneous adipose tissue and only increased energy expenditure when mice had reached a certain thres hold of body weight. 60 Furthermore, increased activity of brown adipose tissue following stimulation by norepi nephrine resulted in increased blood flow and body temperature. 162 Functional brown adipose tissue requires adequate innervation and its activation by sites in the brain and autonomic nervous system for regulation of energy expenditure. 120, 163 one clinical study found no substantial correla tion between whole body thermogenesis and uptake of glucose into brown adipose tissue. 67 Future studies should examine the degree by which human brown adipose tissue uses fatty acid oxidation versus glucose oxidation, as fatty acids can supply up to 90% of the fuel to brown adipose tissue. 162, 164, 165 an estimated 50 g of maximally stimulated brown adipose tissue could account for up to 20% of daily energy expenditure; 166 however, a measure ment of mass or volume of brown adipose tissue does not accurately assess its functional value. For example, in a study in which lean individuals and individuals with overweight or obesity did not have notably different volumes of brown adipose tissue, the level of brown adipose tissue activity, as assessed by 18 F-FDG uptake, was 4.2-fold higher in the lean group than the group with obesity. 67 this result could partially be explained by a potentially higher density of mitochondria, uCP1 and/or degree of activated innervation in lean individuals. thus, the amount of transplanted brown adipose tissue required to achieve beneficial metabolic effects depends on several factors. to achieve long-term benefits, caution is needed to monitor possible downregulation of endo genous uCP1 levels, 167 as well as a reduction of functional brown adipose tissue over time. 167 Adipose-derived stem and progenitor cells Given their multipotency, several factors need to be considered when asCs are engineered to produce beneficial meta bolic effects in humans (Box 1). Firstly, because asCs from elderly donors can lose their capacity to differen tiate, [168] [169] [170] optimal asCs should be obtained from young, healthy donors and have a normal karyotype and a high potential for proliferation and differentiation in vivo. moreover, asCs suppress immunomodulatory properties, [156] [157] [158] which might allow for a tumorigenic potential. 171 secondly, to increase efficiency of brown or white adipogenesis, asCs can be reprogrammed by forced expression of UCP1, PPARγ or PRDM16; or by treatment with BmP7 or retinoic acid. 172 in the future, expression of specific mirnas could also potentially be used to promote adipogenesis, with simultaneous inhibition of differentiation into unwanted cell lineages. 173 For animal studies, this type of forced gene expression has often employed adenoviral vectors, which, however, can stimulate inflammatory responses. 174 For use in humans, safer, non-viral reprogramming will be necessary with the use of other vectors or other delivery methods; for example, microbubbles which contain plasmid Dna can be triggered to release their contents into specific tissues by ultrasound, which has been successfully demonstrated for muscle, vessels 175 as well as the delivery of small interfering rnas into multipotent mesenchymal stem cells for transplantation. 176 thirdly, delivery of asCs into the recipient can be achieved by subcutaneous injection, transplantation, injection into the injured tissue or by intravenous injection, where asCs home to the injured tissue. 177, 178 For experimental studies, the migration of asCs can be followed in real time by bioluminescence microscopy 177 or with the use of green fluorescent protein-expressing cells. 179 increased cell survival and lipid content of asCs differentiated into adipose tissue after transplantation have been reported with the use of hydrogels, 180 the polymer poly(lactic-co-glycolic acid) 181 increase survival of adipose tissue grafts. vascularization might also be increased by mechanical injury, such as abrasion at the transplantation site, and thereby improve survival of adipose tissue grafts. 190 whether these scaffolds and growth factors can help increase the survival and beneficial effects of brown adipose tissue transplants derived from asCs by increasing proliferation, differentiation, vascularization and innervation over the long term requires further investigation.
Previous studies demonstrate that adipocyte pro genitors, isolated by flow cytometry, can also be transplanted to form adipose tissue in mice. [142] [143] [144] lipoaspirates from subcutaneous white adipose tissue of humans could potentially be used to isolate adipocyte progenitors, which could then be engineered ex vivo and retransplanted into the original donor (Figure 3) . Ex vivo engineer ing could involve the overexpression of benefi cial adipokines, such as adiponectin, or involve the promotion of a beneficial white or brown cell fate. For example, adipocyte pro genitors, obtained by culturing human subcutaneous white adipose tissue treated with thiazolidinediones, developed into brown adipocytelike cells, which expressed uCP1 and had increased oxygen consumption and energy expenditure, in vitro. 191 an alternative would be to isolate brown adipocyte progenitors from skeletal muscle-more specifically myofiber-associated cells-with the use of cell sorting techniques, such as fluorescence-activated cell sorting. 81 skeletal muscle-derived progenitors are already in clinical trials for the repair of cardiac infarct. 192 studies have suggested that some brown adipocytes may also have a muscle-related origin (Y.-H. tseng, personal communication), 82 but whether these cells are the same or different precursors remains to be determined. in either case, ex vivo engineering with BmP7 or thiazolidine diones could be used to promote differentiation of brown adipose tissue. transplanted and engineered mesen chymal stem cells have shown some spontaneous innervation of the newly formed brown adipose tissue in animal models; 78, 79, 137 however, other manipulations might be needed to obtain robust innervation and vascularization of adipose tissue formed from adipocyte progenitors transplanted into humans. Pet-Ct and other imaging techniques could prove useful to monitor both the mass and metabolic activity of the 193 nonetheless, many technical challenges, such as the dose of cells, the nature of the scaffolds and the necessary growth factors to support differentiated function, still remain. other questions which need to be addressed include efficient and safe procedures for collection, expansion, storage and delivery of cells. 139, 196 these issues are also discussed in a review by Zhang. 197 Conclusions the goal of adipose tissue transplantation has evolved dramatic ally from the early uses for esthetic and reconstruc tive surgery to the study of adipose tissue biology, and now, as a potential tool to provide beneficial metabolic effects for the prevention or treatment of meta bolic pathologies. the potential for transplantation of brown adipose tissue has been acknowledged with the dis covery that active brown adipose tissue is inversely corre lated with Bmi, adipose tissue mass, glucose and insulin levels in humans. nevertheless, more detailed metabolic charac terization of brown adipose tissue in humans is needed, in terms of fat oxidation, potential adipo kines and mecha nisms of brown adipose tissue activation in response to stimuli (for example, cold or drugs). in addition, the identification of critical re gulators of brown adipose tissue cell fate, such as BmP7 and PrDm16, as well as the identification of progenitors of brown adipocytes from skele tal muscle have raised the possibility of inducing other progenitor cells to form brown adipose tissue-a second strategy to increase brown adipose tissue mass. similarly, subcutaneous white adipose tissue might have beneficial metabolic effects, and its cell-autonomous properties are often studied in relation to its well-known protective adipo kines, such as adiponectin. more studies, however, are necessary to discover and characterize its other proper ties, such as other adipokines, develop mental genes, mirnas and its increased response to insulinsensitizing drugs, all of which raise the notion that transplantation or induction of specific types of white adipose tissue could improve metabolism. novel uses of growth factors, regulators of differentiation and scaffolds should be explored, in order to better purify, modulate, expand and/or maintain brown adipose tissue, sub cutaneous white adipose tissue and asCs. Better understanding of the loss of function of brown adipose tissue and asCs with aging, as well as in vitro serial culture and tumorigenesis, will provide new targets for reprogramming of cells for trans plantation and maintenance. whether trans plantation of adipose tissue and its component cells, with or without tissue engineering, could provide a treatment for many disorders beyond classic metabolic diseases is not yet known. the overall value of these types of adipose tissue transplantation will ultimately be determined by their long-term benefits and safety compared with present therapies.
Review criteria
A search for original articles published between 1913 and 2009 that focused on the transplantation of adipose tissue was performed in PubMed. The search terms used were "fat and transplantation", "fat and graft", "adipose and transplantation", "adipose and graft", "brown and transplantation", "brown and graft", "cells and transplantation and ppar", "cells and graft and ppar", "fat and stem cells" and "adipose and stem cells". we also searched the reference lists of identified articles for further papers.
